Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-1-9
pubmed:abstractText
Dendritic cells (DCs) were pulsed with the H-2K(b) binding OVA(257-264)-peptide (SIINFEKL), and used as one single-injection vaccine in combination with anti-CTLA-4 monoclonal antibody (mAb) to treat mice inoculated 3 days previously with 3x10(5) E.G7-OVA lymphoma cells. Neither DC vaccination nor CTLA-4 blockage alone prevented tumor growth in tumor challenged mice. In contrast, the combination of one vaccination and injection of anti-CTLA-4 mAb lead to rejection or retarded tumor growth in more than 60% of the mice. The OVA-transgene or the SIINFEKL-epitope was not lost in the progressing tumors of vaccinated mice, however, the highest degree of anti-SIINFEKL reactivity of host CTLs in an IFN-gamma ELISPOT assay was found only in mice showing complete tumor rejection. Vaccinated mice having rejected E.G7-OVA tumors were capable of rejecting subsequent challenges with 1x10(6) E.G7-OVA tumor cells, and later on these mice even rejected wild-type EL-4 tumor cells indicating that tumor epitope spreading takes place during the process of vaccination-induced E.G7-OVA rejection. In agreement with these observations, mice having rejected E.G7-OVA tumors showed long lasting CTL memory in spleen and bone marrow towards both the SIINFEKL-peptide and other EL-4-derived tumor rejecting epitopes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation, http://linkedlifedata.com/resource/pubmed/chemical/CTLA-4 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Ctla4 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Egg Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, http://linkedlifedata.com/resource/pubmed/chemical/H-2 Antigens, http://linkedlifedata.com/resource/pubmed/chemical/H-2Kb protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/OVA-8, http://linkedlifedata.com/resource/pubmed/chemical/Ovalbumin, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0304-3835
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
231
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
247-56
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16399226-Animals, pubmed-meshheading:16399226-Antibodies, Monoclonal, pubmed-meshheading:16399226-Antigens, CD, pubmed-meshheading:16399226-Antigens, Differentiation, pubmed-meshheading:16399226-Bone Marrow, pubmed-meshheading:16399226-CTLA-4 Antigen, pubmed-meshheading:16399226-Cancer Vaccines, pubmed-meshheading:16399226-Dendritic Cells, pubmed-meshheading:16399226-Drug Therapy, Combination, pubmed-meshheading:16399226-Egg Proteins, pubmed-meshheading:16399226-Epitopes, pubmed-meshheading:16399226-Female, pubmed-meshheading:16399226-H-2 Antigens, pubmed-meshheading:16399226-Lymphoma, pubmed-meshheading:16399226-Mice, pubmed-meshheading:16399226-Mice, Inbred C57BL, pubmed-meshheading:16399226-Ovalbumin, pubmed-meshheading:16399226-Peptide Fragments, pubmed-meshheading:16399226-Signal Transduction, pubmed-meshheading:16399226-Spleen, pubmed-meshheading:16399226-T-Lymphocytes, Cytotoxic, pubmed-meshheading:16399226-Thymoma, pubmed-meshheading:16399226-Transgenes, pubmed-meshheading:16399226-Vaccination
pubmed:year
2006
pubmed:articleTitle
The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling.
pubmed:affiliation
Department of Medical Anatomy, The Panum Institute, The University of Copenhagen, Blegdamsvej 3, Copenhagen 2200N, Denmark. ome@mai.ku.dk
pubmed:publicationType
Journal Article